Beam Therapeutics (BEAM) just released new BEACON trial data on its sickle cell therapy risto cel, showing durable hemoglobin F gains, lower hemoglobin S, and anemia resolution that help explain the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback